DR REDDY operates within the Healthcare sector, specifically in the Drug Manufacturers – Specialty & Generic industries. Listed on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), Dr. Reddy’s Laboratories Ltd has a significant presence in the Indian stock market.
Join Us On WhatsApp GroupIn this detailed analysis, we will explore Dr. Reddy’s share price targets for 2025, 2026, and beyond, up to 2030. To forecast these long-term targets, we will employ various technical analysis methods.
To predict DRREDDY’s share prices up to 2030, we will use a machine learning model that bases its forecasts on historical performance. Over the years, Dr. Reddy’s Laboratories has demonstrated diverse trends.
This section will discuss DRREDDY’s current market position, its growth trajectory, financials and fundamentals of its price performance leading up to 2030.
Fundamental Analysis
| Market Cap | ₹1,01,987.13 Cr |
| ROE | 19.54% |
| ROCE | 25.52% |
| P/E | 19.07 |
| P/B | 3.53 |
| Div. Yield | 0.65% |
| Book Value | ₹345.81 |
| Face Value | ₹1 |
| EPS (TTM) | ₹64.11 |
| 52 Week High | ₹1,421.49 |
| 52 Week Low | ₹1,020.00 |
Also Read: Inox Wind Share Price Targets 2025 to 2030
Share Price Target 2025
- Starting Price: ₹1,275
- Mid-Year Price: ₹1,375
- Ending Price: ₹1,480
Share Price Target 2026
- Starting Price: ₹1,520
- Mid-Year Price: ₹1,580
- Ending Price: ₹1,640
Share Price Target 2027
- Starting Price: ₹1,680
- Mid-Year Price: ₹1,750
- Ending Price: ₹1,820
Also Read: HAL Share Price Targets 2025 to 2030
Share Price Target 2028
- Starting Price: ₹1,860
- Mid-Year Price: ₹1,930
- Ending Price: ₹2,000
Share Price Target 2029
- Starting Price: ₹2,050
- Mid-Year Price: ₹2,130
- Ending Price: ₹2,210
Share Price Target 2030
- Starting Price: ₹2,280
- Mid-Year Price: ₹2,360
- Ending Price: ₹2,450
Also Read: Aban Offshore Share Price Targets 2025 to 2030
Dr Reddy Share Price Targets 2025 to 2030
| Year | Share Price Target (₹) |
|---|---|
| 2025 | 1,275 – 1,480 |
| 2026 | 1,520 – 1,640 |
| 2027 | 1,680 – 1,820 |
| 2028 | 1,860 – 2,000 |
| 2029 | 2,050 – 2,210 |
| 2030 | 2,280 – 2,450 |
Shareholding Pattern
| Retail & Others | 10.45% |
| Promoters | 26.64% |
| Foreign Institutions | 37.29% |
| Mutual Funds | 12.88% |
| Other Domestic Institutions | 12.73% |
Key Competitors
Key competitors or peer companies of Dr. Reddy are Sun Pharmaceutical Industries, Cipla, Mankind Pharma, Zydus Lifesciences, Lupin, Aurobindo Pharma, Alkem Laboratories, Glenmark Pharmaceuticals, IPCA Laboratories, and Alembic Pharmaceuticals.
Also Read: Shalimar Production Share Price Targets 2025 to 2030
FAQs
What is the Dr Reddy Share Price Target 2035?
The price target for Dr Reddy in 2035 is projected to range from ₹3,070 to ₹3,300.
What is the Dr Reddy Share Price Target 2040?
The price target for Dr Reddy in 2040 is projected to range from ₹4,100 to ₹4,410.
What is the Dr Reddy Share Price Target 2050?
The price target for Dr Reddy in 2050 is projected to range from ₹6,050 to ₹6,560.
Disclaimer: The stock market updates shared by DateUpdateGo are solely for general information and learning purpose only. They are not meant to serve as an investment advice. Individuals should always seek guidance from a certified financial advisor before making any investment-related choices.